Replacing ritonavir by nelfinavir or nelfinavir/saquinavir as part of highly active antiretroviral therapy leads to an improvement of triglyceride levels. [electronic resource]
Producer: 20020118Description: 2191-3 p. digitalISSN:- 0269-9370
- Adolescent
- Adult
- Anti-HIV Agents -- therapeutic use
- Drug Therapy, Combination
- HIV Infections -- drug therapy
- HIV Protease Inhibitors -- therapeutic use
- HIV-1 -- isolation & purification
- Humans
- Nelfinavir -- therapeutic use
- Reverse Transcriptase Inhibitors -- therapeutic use
- Ritonavir -- therapeutic use
- Saquinavir -- therapeutic use
- Treatment Outcome
- Triglycerides -- blood
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.